peptide formulationLyophilized Peptide Formulations: Stability Findings and Limits

Lyophilized Peptide Formulations: Stability Findings and Limits

Measured stability findings for lyophilized peptide formulations, with implications for research coordination and evidence review.

A CSP7 peptide formulation retained more than 95% in solution at 5 and 25 °C for 48 hours and remained stable for up to 10 months at 5 °C when protected from moisture.

P
PeptideStaff Research Team
||3 min read|10 sources

Stability has more than one endpoint

Lyophilization changes water activity and can improve handling, but the result depends on peptide sequence, excipient, cake structure, container closure, residual moisture, reconstitution, and storage environment. A stability claim should identify which endpoint was measured: intact assay, related substances, aggregation, appearance, reconstitution, or biological function.

A measured formulation example

In a 2017 CSP7 study, solution retained more than 95% peptide at 5 and 25 °C for up to 48 hours and tolerated at least five freeze-thaw cycles. Lyophilized cakes with excipients remained above 96% for up to four weeks at room temperature, and more than 98% remained in solution eight hours after reconstitution at room temperature. Protected from moisture at 5 °C, formulations were stable for up to 10 months; exposure to 75% relative humidity increased absorbed moisture and induced reversible aggregates. The study used a specific peptide and formulation set, so these percentages are not generic specifications.

Research operations

The evidence record should connect formulation code, vial and batch, cycle, storage temperature, humidity exposure, timepoint, reconstitution conditions, analytical method, replicate count, and disposition rationale. Coordinators can preserve that chain and route anomalies; formulation and analytical scientists own conclusions.

Evidence limits

The CSP7 work is a formulation study, not a clinical stability program, and the 10-month result was at 5 °C with moisture protection. ICH and FDA guidance frame stability design but cannot replace product-specific forced-degradation and long-term data.

Source register

The ten URLs above form this article's topic-specific register, combining the primary CSP7 study with ICH stability/quality guidance, FDA materials, and peptide stability literature.

Report the cycle and the resulting cake

The CSP7 study measured more than 95% peptide remaining in solution at 5 and 25 °C for 48 hours and at least five freeze-thaw cycles. Lyophilized cakes remained above 96% for four weeks at room temperature, and more than 98% remained in solution eight hours after reconstitution. A protected formulation stored at 5 °C was reported stable for up to 10 months, while 75% relative humidity increased absorbed moisture and produced reversible aggregates. These values belong to one formulation set and cannot establish a shelf life for another peptide.

Compare matched vials with documented freezing, primary-drying, storage, humidity, and reconstitution conditions. Record residual moisture, assay, related substances, aggregation, appearance, reconstitution time, and biological activity separately, with units, replicates, and pull dates. A coordinator can maintain the vial map, chamber logs, pull schedule, and raw-data links; formulation, analytical, and quality owners decide whether a cycle or container advances.

Sources & Citations

  1. https://pubmed.ncbi.nlm.nih.gov/28835128/
  2. https://database.ich.org/sites/default/files/Q1A_R2_Guideline.pdf
  3. https://database.ich.org/sites/default/files/Q1B_Guideline.pdf
  4. https://database.ich.org/sites/default/files/Q5C_Guideline.pdf
  5. https://database.ich.org/sites/default/files/Q6A_Guideline.pdf
  6. https://database.ich.org/sites/default/files/Q8_R2_Guideline.pdf
  7. https://www.fda.gov/media/193346/download
  8. https://www.fda.gov/media/193343/download
  9. https://www.fda.gov/media/149068/download
  10. https://pubmed.ncbi.nlm.nih.gov/35732861/

Topics

peptide-formulationlyophilizationstabilityanalytical-research
PR

PeptideStaff Research Team

Peptide Industry Research & Analytics

Market research analysts | peptide industry data specialists | healthcare economists

Our research team aggregates and analyzes publicly available data from regulatory agencies, market research firms, and clinical databases to deliver statistics-backed insights for peptide business owners. All statistics are sourced and cited.

Published by the PeptideStaff Research Team, July 2026